You are here: Industry Insights > leukemia

News List

New targeted treatment for relapsed or refractory acute myeloid leukemia approved by FDA biospectrumasia
August 03, 2017
Idhifa is an isocitrate dehydrogenase-2 inhibitor that works by blocking several enzymes that promote cell growth
Discovery of protein mutations may lead to better therapies for Leukemia biospectrumasia
June 23, 2017
A team of scientists at Children’s Hospital of Philadelphia (CHOP), led by Wei Tong, a hematology researcher reveals how mutated proteins cause several types of leukemia. This new understanding of the molecular mechanisms at work may offer clues to other
New leukemia treatment outperforms standard chemotherapies biospectrumasia
June 13, 2017
Around 1,000 people are diagnosed with AML in Australia each year and, depending on the patient's age, there is a high rate of mortality with only about 30 percent surviving long term
EMA validates application for BMS’s Sprycel in children with chronic myelogenous leukemia cphi-online
May 25, 2017
Proposal extends application to the treatment of children and adolescents with chronic phase Philadelphia-chromosome positive chronic myelogenous leukemia and to the powder for oral suspension.
Gleevec Keeps a Leukemia in Check for More Than a Decade: Study drugs.com
March 09, 2017
The cancer drug Gleevec appears to keep chronic myeloid leukemia at bay a decade into treatment -- with no signs of additional safety risks, a new study finds.
A Review of Leukemia Targeting Drugs in 2016: Small Molecule Drugs and Monoclonal Antibody Drugs Par en-cphi
February 10, 2017
Leukemia is a clonal disease caused due to mutation of human hematopoietic stem cells, can cause symptoms like bleeding, anemia, organ infiltration and intestinal function failure of patients, and is a human disease of great harm.

Previous page 1 2 3 4 5 Next page